Carl Dambkowski, the Chief Medical Officer of $APGE, sold 2,725 shares of the company on 08-06-2025 for an estimated $102,950. We received data on the trade from a recent SEC filing. This was a sale of approximately 1.1% of their shares of this class of stock. Following this trade, they now own 236,273 shares of this class of $APGE stock.
$APGE Insider Trading Activity
$APGE insiders have traded $APGE stock on the open market 12 times in the past 6 months. Of those trades, 0 have been purchases and 12 have been sales.
Here’s a breakdown of recent trading of $APGE stock by insiders over the last 6 months:
- CARL DAMBKOWSKI (Chief Medical Officer) has made 0 purchases and 10 sales selling 23,715 shares for an estimated $944,303.
- MICHAEL THOMAS HENDERSON (Chief Executive Officer) has made 0 purchases and 2 sales selling 10,000 shares for an estimated $301,511.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$APGE Hedge Fund Activity
We have seen 82 institutional investors add shares of $APGE stock to their portfolio, and 87 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- OCTAGON CAPITAL ADVISORS LP added 10,700,000 shares (+inf%) to their portfolio in Q1 2025, for an estimated $399,752,000
- WELLINGTON MANAGEMENT GROUP LLP added 968,391 shares (+21.4%) to their portfolio in Q1 2025, for an estimated $36,179,087
- JPMORGAN CHASE & CO added 925,376 shares (+2483.9%) to their portfolio in Q1 2025, for an estimated $34,572,047
- MERCER GLOBAL ADVISORS INC /ADV added 920,079 shares (+127.8%) to their portfolio in Q1 2025, for an estimated $34,374,151
- JANUS HENDERSON GROUP PLC added 658,733 shares (+58.0%) to their portfolio in Q1 2025, for an estimated $24,610,264
- POLAR CAPITAL HOLDINGS PLC added 550,000 shares (+inf%) to their portfolio in Q1 2025, for an estimated $20,548,000
- ADAGE CAPITAL PARTNERS GP, L.L.C. added 486,800 shares (+202.7%) to their portfolio in Q1 2025, for an estimated $18,186,848
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$APGE Analyst Ratings
Wall Street analysts have issued reports on $APGE in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Guggenheim issued a "Buy" rating on 07/02/2025
- Citigroup issued a "Buy" rating on 03/13/2025
To track analyst ratings and price targets for $APGE, check out Quiver Quantitative's $APGE forecast page.
$APGE Price Targets
Multiple analysts have issued price targets for $APGE recently. We have seen 2 analysts offer price targets for $APGE in the last 6 months, with a median target of $105.5.
Here are some recent targets:
- Seamus Fernandez from Guggenheim set a target price of $116.0 on 07/02/2025
- Geoff Meacham from Citigroup set a target price of $95.0 on 03/13/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
